Immunai launches out of stealth with $20 million in funding, as biotech remains a bright spot in an otherwise turbulent startup ecosystem

· A new biotechnology startup backed by two Israeli VCs, TLV Partners and Viola Ventures, launched out of stealth with $20 million in funding on Thursday. 
· Immunai says it uses single cell technologies and machine learning algorithms to map out immune cells, to provide data for researchers and pharmaceutical firms for use...